The Salutogenic Effects of Cow’s Milk and Dairy Products in Celiac Disease
Received Date: Mar 23, 2018 / Accepted Date: Apr 13, 2018 / Published Date: Apr 18, 2018
For the last 10,000 years human beings consume cow’s milk. Along the evolution, human gut adapted to consume animals’ milks for man benefits. Poured cow’s milk, dairy food and bacterial fermented dairy products contain multiple health promoting and therapeutic factors that might help in multiple autoimmune diseases, including celiac disease. The present review summarizes the celiac disease pathophysiology and dysfunctions that can benefit from cow’s milk and dairy food health promoters, on the preventive as well as on the therapeutic levels. The extended list of milk originated, bio-reactive agents forms a basis, and hopefully the drive for further studies in order to explore the beneficial compound buried in this biologically active and natural fluid and dairy products.
Keywords: Cow’s milk; Dairy products; Bacterially fermented milk products; Bioactive compounds; Health-promotion; Celiac disease
CD: Celiac Disease; GFD: Gluten Free Diet
Human beings are consuming cow’s milk since cattle were domesticated in the early Neolithic age, around more than 10,000 years ago. Along the evolution, human gastrointestinal tract adapted to consume animal milks, cow’s milk being the major one. During thousands of years humanity benefited from cow’s milk drinking and dairy products consumption as health promoters. It is only in the last decades that critics and drawbacks were related to its consumption and mainly popular reports categorized it to be detrimental to human health. It has been related to various conditions like cancers, autoimmune diseases, atherosclerosis, hypercholesterolemia, aging, acne and constipation . Most of those publications are associative, where no cause and effects were demonstrated. On the contrary, the last years brought us huge amount of scientific observations on the cow’s milk content, harboring multiple bio-active factors in the whey and the Casein compartments or were produced during bacterial fermentation. Cow’s milk and dairy products are considered nowadays as health-promoting foods, some of them even as beneficial functional nutrients [2-6]. The aim of the present review is to update on those health-promoting compounds in relation to the potential beneficial effects they can offer as an adjuvant therapy, to Celiac Disease (CD)
Cow’s milk and dairy products contents
Raw cow’s milk contains 30-35 g of protein per litre; about 80% is arranged in casein micelles. Total proteins in milk represent 3.2% of its composition and are divided to whey and casein portions. Milk contains various carbohydrates including mono-, di-, oligosaccharides, whereas the main one is lactose which gives milk its sweetness and contributes approximately 40% of whole cow's milk's calories. Milk fat is secreted in form of a fat globule surrounded by a membrane. The fatsoluble vitamins A, D, E, and K along with essential fatty acids such as linoleic and linolenic acid are found within the milk fat portion of the milk. In addition, milk contains multiple minerals: calcium, phosphate, magnesium, sodium, potassium, citrate, and chlorine, salts of calcium and phosphates, vitamins: A, B6, B12, C, D, K, E, thiamine, niacin, biotin, riboflavin, folates, and pantothenic acid, and immunoglobulins, living white blood cells, mammary gland cells, various bacteria, and numerous active enzymes [5,6]. During processing, bacterial fermentation and by supplementing food additives, additional bioactive compounds appear that will be reviewed below.
Celiac disease is an autoimmune inflammatory condition of the small intestine, triggered by the ingestion of prolamins contained in wheat, barley, rye or oat, in genetically susceptible individuals. The accepted incidence of CD averages 1-2% in the Western world, the majority of patients being undiagnosed . Comparable to the predominance of the female gender in many other autoimmune diseases, the male/female ratio in CD is 1:2-3.
The epidemiology and phenotype of CD are constantly evolving. The classic intestinal clinical picture of malnutrition, chronic diarrhea and nutritional deficiencies are disappearing and extraintestinal presentations are emerging. Skin, endocrine, skeletal, hepatic, hematological, thrombophilic, gynecological, fertility, dental, psychiatric and behavioral abnormalities are increasingly described . An epidemiological shift in the disease phenotype toward a more advanced age, and increased prevalence of latent, hyposymptomatic or asymptomatic behavior is observed. Increased risk of complications such as hematological and gastrointestinal malignancies, osteoporosis/ penia and other extraintestinal manifestations like hepatitis, decreased height, malnutrition, nutritional deficiencies, fertility impairment, stillbirth, dysmaturity, psychosocial deterioration, impairment of quality of life, increased mortality and additional autoimmune conditions, if left untreated, are faced by the patients. Thus, early diagnosis and subsequent adherence to a gluten-free diet (GFD) is highly recommended [8-11].
Bioactive Compounds in Cow’s Milk and Dairy Products with Potential Benefits in Celiac Disease
Celiac disease is an inflammatory, oxidative, apoptotic, tissue destructive and a dysbiotic condition. It is characterized by activation of the innate and reactive immune systems, surge in pro-inflammatory cytokines and activation of the autoimmune cascade. Being associated with increased incidence of type 1 diabetes, failure of the mucosal immune network and tolerance break toward gluten, hypercoagulability and nutritional insufficiencies, CD patients can benefit from numerous bio-active components which raw cow’s milk, dairy products and bacterially fermented milk can offer. (Table 1) summarizes those compounds in relation to CD pathophysiological abnormalities.
|Cow’s milk and dairy components||Compound activity||Celiac disease abnormalities||References|
|α- ,β||Casomorphins: ↗ AA, electrolyte absorption||↘absorption||12,13|
|Casokinins: ↗ intestinal blood supply||Intestinal damage||12|
|Phospholipids: electrolyte binding+ absorption||12,13|
|Immunopeptides, Casomorphins, Casokinins: ↗ immune+phagocytic activities||Immune+phagocytic insufficiencies||12|
|κ||Casoplatelins: anti-thrombotic, coagulability||hypercoagulability||12,14|
|ȇ-caseinglyco: probiotic, ↗ bifidobacteria||Dysbiosis, ↘bifidobacteria||12|
|αs1||Isracidin: Antimicrobial, antioxidative||12,15|
|αs2||Casocidin: antimicrobial||Microbial induced||12,15|
|Immunoglobulins: IgG, IgA||Immunomodulators||IgA deficiency, immune deficiency||12,15|
|Lactoferrin||Anti-microbial,-inflammatory, Probiotic, ↗bifidobacteria||Dysbiosis, ↘bifidobacteria, microbial induced||12,15-17|
|Oligosaccharides||Probiotic, ↗bifidobacteria||Dysbiosis, ↘bifidobacteria||12, 16, 17|
|Glycolipids||Antimicrobial||↘prokaryotic epithelial attachment||12,15|
|Cytokines: IL-1,2,6,10, TNF α, INF γ TGF α, leukotriene B4, prostaglandin E2||Immunomodulation Cellular trafficking||Hyperactivity of innate+ reactive systems leading to intestinal damage||12,18|
|Growth factors: IGF 1, TGF α, EGF, TGF β||Organ development, growth and functions||Intestinal destruction,↘rehabilitation, dysfunction||12,19|
|β lactoglobuline||Rich in branched AA||↘absorption, nutritional deficiencies||12,13|
|α lactalbumin||Rich in tryptophan||↘absorption, nutritional deficiencies||12,13|
|Glycomacropeptides||Rich in essential AA||↘absorption, nutritional deficiencies||12,13|
|Albumin||High biological value, proteins and factors carrier||↘absorption, nutritional deficiencies||12,13|
|Parathormone-P||↗Ca absorption and metabolism||↘ Ca absorption, osteopenia, osteoporosis||12,20|
|Prolactin||Immune modulation||immune destructive hyperactivity||12,19,21|
|Bacterial dairy fermentation products|
|Vitamins: B-1,2,7,9,12||Specific biological activities||↘absorption, nutritional deficiencies||2-4,12,13|
|Gamma-Aminobutyric Acid||Anti-diabetic||↗incidence of type 1 diabetes||2,22|
|Bacteriocins||Antimicrobial||Dysbiosis, microbial induced||2, 15,17|
|exopolysaccharides||Antimicrobial, immunomodulator||Dysbiosis, microbial induced, immune destructive hyperactivity||2,15,17,19|
Table 1: Health promoting compounds in cow’s milk and dairy products, originated from: 1A-casein proteins, 1B- whey factors and 1C-bacterial fermentations induced compounds, having preventive and therapeutic potentials in celiac disease. [2-4,12]. AA-amino acids, Ca-calcium, ↗- increase, ↘-decrease
Bone Health, Dairy Products and Celiac Disease
Most of CD patients today are diagnosed during adulthood and around half of them present decreased bone mineral density at diagnosis . When a general CD US population was screened, children and men had reduced bone mineral density and men ≥ 40 years had increased risk of osteoporotic fractures . Many conditions and circumstances can contribute to the skeletal alterations in CD. Hypocalcaemia of various etiologies, hypovitaminosis D, the inflammatory state of the small bowel, bone related hormones, associated autoimmune diseases, active or non-responsive disease, life factors like reduced physical activity and smoking and bone affecting drug intake, but above all is the calcium status, being the “common denominator of bone and intestine” . Nutrition represents a major factor in proper bone mineralization and upon gluten withdrawal, calcium intake may be reduced. In fact, GFD is low in vitamin D and calcium, intake of milk and dairy products is reduced in order to avoid lactose and seldom gluten-free products are enriched with calcium and vitamin D. Thus, adherence to GFD, a well-balanced diet and adequate consumption of dairy products is highly recommended . The highest calcium nutrients are represented by milk and dairy foods which provide also vitamin D, potassium, magnesium, proteins and other micro and macro compounds. Those products positively affect bone mass accretion and maintenance during the whole life cycle, thus lowering the risk of fractures later in life, including in CD [26-30].
Milk Products and the Dysbiosis of Celiac Disease
An intricate human-microbe symbiotic relation in the gut lumen has coevolved since the beginning of humanity, for the last two million years. The adaptation and fine-tuning of the two kingdoms benefit both to the degree that one cannot survive without the other [16,17]. The enteric bugs protect us from systemic diseases, intestinal infections, drive the gut immune systems and produce a mobilome, acting as metabolic organ that support the homeostasis of gut and systemic essential biological events [31-33]. The literature suggests that in CD, there are abnormalities in the composition and diversity of the microbiome [16,17] and its metabolic activity . Zooming back on cow’s milk and dairy products benefits, the two families of bifidobacteria and lactococcus are less abundant in CD intestinal lumen and stools, while multiple casein and whey compounds are inducing or maintaining their growth [1,4,34-38]. More specifically, κ- casein, Lactoferrin and Oligosaccharides, were shown to induce or maintain bifidobacteria spp (Table 1). Interestingly, Bifidobacteria and lactobacilli are capable to degrade immunotoxic gluten peptides, resulting in a new potential therapeutic modality for CD [19,39,40]. In a wider angle, those microbial components are associated with additional autoimmune diseases like type 1 diabetes, inflammatory bowel diseases and thyroid autoimmunity and with non-autoimmune conditions like irritable bowel syndrome [41-43].
Whey proteins can modulate gut microbiome, thus preserving intestinal health and by their probiotic functions, dairy products are potential drivers of a more physiological mobilome, whereby short chain fatty acids is a good example [32,35]. Interestingly, a recent study analyzing breast milks of CD mothers showed decreased numbers of Bifidobacterium spp , compared to control breast milk . The impact of CD mother’s milk microbiota on CD development of their offspring is still unknown.
Milk Products and Intestinal Permeability
Multiple intestinal luminal environmental factors and eco-events can perturb tight junction integrity, resulting in a leaky gut [33,45], thus breaking equilibrium between tolerance and immunity to nonself- antigens. Nutrients that are enhancing or breaching tight junction performance were summarized lately . Many of the enhancers originate from cow’s milk, dairy food, bacterially fermented milk products or supplementations. Short chain fatty acids like butyrate, polyunsaturated fatty acids, certain amino acids like glutamine, trace elements like zinc, vitamins like A and D, carotenoids, retinoids and proteases are some of them [33,46-49]. More so, in recent years, the fermented dairy industries are very productive in finding or adding health promoting factors to their products. Fruits to introduce fibers as prebiotics, polyphenols as a defence and antioxidant compounds, flavonoids, probiotics and other factors that protect the intestinal luminal compartment and the mucosal integrity, were recently described [50-54]. Finally, as increased intestinal permeability exists in CD patients, those dairy products can attenuate tight junction dysfunction for the benefit of the gluten sensitive populations.
IgA Deficiency, Dairy Products and Celiac Disease
Selective IgA deficiency is a frequent genetic immunodeficiency state. IgA antibodies are responsible for combating pathobionts along mucus membranes that are constantly exposed to the environment and are important in maintaining the physiological immune balance in the gut lumen. It is relative resistant to the intestinal proteases with a longer half-life. IgA deficient people should be tested for CD since they are 10-20 times more likely to develop the disease . Unfortunately, IgA deficient people are in high risk for additional autoimmune diseases like rheumatoid arthritis and lupus. It is estimated that 2% of CD affected people have selective IgA deficiency. Cow’s milk and mainly colostrum contain IgA and many dairy-based functional products are fortified with colostrum, thus rich in IgA . The dairy IgA should be added to the multiple antimicrobial compounds embedded in cow’s milk originated products to fight gastrointestinal infections (Table 1). Interestingly, IgA expressing food products are in process of being developed .
Secondary Lactose Intolerance and Celiac Disease
Lactose malabsorption occurs secondarily in CD. Patients, once on GFD, lactase activity will gradually return to normal, following the mucosal recovery .
Unabsorbed lactose is a driver of bifidobacteria proliferation and facilitates calcium absorption. Thus, it is presenting an additive effect to the other probiotic and bifidogenic factors and calcium absorption enhancers in dairy products (Table 1). So, in view of the modern trends and before a sweeping suggestion for long term lactose avoidance, which often goes with cow’s milk and dairy food withdrawal, all the above mentioned health promoting features of the lactose should be taken in account when treating CD patients. More so, avoidance of milk-based formula in high-risk CD infants or bovine milk intolerance in CD patients does not reduce CD development nor T-cell stimulatory epitopes of gluten, respectively [59,60].
A close evolutionary relationship between cow milk consumption and shaping of intestinal functions and the microbiota composition and diversity exist. However, the recent two centuries since the industrial revolution and the last decades of food processing industrialization and the global nutritional and life style Westernization has reshaped the dynamics of food consumption [33,45,61-64]. Even the celiac patient’s genetic make-up was remodelled during evolution, where protective genes were accumulated for their last 2 millenniums survival . Not less interesting is the external genetic cargo transmitted from the prokaryotes to the eukaryotes, including human cells, by the horizontal gene transfer, thus connecting environmental microbes to human genome . Human immune systems are continuously facing foreign antigenic load and gluten is only one example . In vast majority of the people, it is tolerated, in contrary to the case of gluten mediated condition, were tolerance is breached, resulting in CD and non-CD auto and non-autoimmune chronic diseases . CD has genetic basis but the environmental alterations have created a maladapted state for the body, thus the genetic susceptibility gets uncovered.
For multiple millenniums, milk is a nutrient that human body evolved with. Right from birth, breast milk and then in childhood, adolescence and adulthood, milk from various animal sources was consumed. Our immune system is likely "learnt" to be tolerant to compounds present in milk. But genetic susceptibility factor combined with environmental trigger can unleash the immune system to break the tolerogenic checkpoint. Assessment of food quality by epithelial cells and enteric immune cells like gamma delta T cells, innate lymphoid cells and/or the glial enteric nervous system is constantly unravelled [33,68]. In this regard, cow’s milk has many components that likely our immune system cares about and evaluates. Parallel to the evolutionary stress on the human body, its protective immune machinery, the enteric microbiome and natural foods, the milk producing animal kingdom also experienced evolutionary constrains. Recent changes in farming, use of pesticides, drugs like antibiotics and processed food has also altered cows' diet and potentially the milk it produces. Such altered cow milk when consumed by humans can impact immune monitoring and responses.
Those are several raisons why effort should be concentrated on food quality control. Safe food is the right of every citizen worldwide and the corresponding regulatory authorities should concentrate on safety of animal’s milk and their products’ manufacturing, processing and consumption to avoid any detrimental effects on public health. At least, the European commission and the American FDA have done some recent progress to protect citizens from those foods’ side effects [69,70].
Cow’s milk, dairy food and bacterial fermented dairy products contain multiple preventing, health promoting and therapeutic factors that might help in multiple chronic inflammatory and autoimmune conditions, CD included. The present review summarizes the CD abnormalities and dysfunctions that can benefit from cow’s milk and dairy food health promoters, on the preventing, as well as, on the therapeutic aspects. It should be stressed that many of the beneficial effects of cow’s milk and dairy products were shown on animal or cellular models and not directly on CD patients. The extended list of milk originated, bio-reactive agents forms a basis, and hopefully the drive to further study and explore the beneficial compounds buried in this biologically active and natural fluid and products, in vivo .
Author would like to acknowledge the contribution from the coauthors.
- Campbell T (2014) “12 frightening facts about milk.” t. colin campbell center for nutrition studies.
- Linares DM, Gomez C, Renes E, Fresno JM, Tornadijo ME, et al. (2017) Lactic Acid Bacteria and Bifidobacteria with Potential to Design Natural Biofunctional Health-Promoting Dairy Foods. Front Microbiol 8: 846.
- Marco ML, Heeney D, Binda S, Cifelli CJ, Cotter PD, et al. (2017) Health benefits of fermented foods: microbiota and beyond. Curr Opin Biotechnol 44: 94-102
- Fernández M, Hudson JA, Korpela R, de los Reyes-Gavilan CG (2015) Impact on human health of microorganisms present in fermented dairy products: an overview. Biomed Res Int 2015: 412714
- Ebringer L, Ferencík M, Krajcovic J (2008) Beneficial health effects of milk and fermented dairy products--review. Folia Microbiol (Praha) 53: 378-394.
- Capriotti AL, Cavaliere C, Piovesana S, Samperi R, Lagana A (2016) Recent trends in the analysis of bioactive peptides in milk and dairy products. Anal Bioanal Chem 408: 2677-2685.
- Lerner A, Matthias T (2017) Extraintestinal manifestations of CD: Common pathways in the gut-remote organs’ axes. Internat J Celiac Dis 5: 24-27.
- Lerner A, Jeremias P, Neidhofer S, Matthias T (2016) Antibodies against neo-epitope tTg complexed to gliadin are different and more reliable then anti-tTg for the diagnosis of pediatric celiac disease. J Immunol Methods 429: 15-20.
- Lerner A, Neidhofer S, Matthias T (2015) Serological markers and/or intestinal biopsies in the case-finding of celiac disease. Int J Celiac dis 3: 53-55.
- Lerner A, Matthias T (2015) Increased knowledge and awareness of celiac disease will benefit the elderly. Int J of Celiac Dis 3: 112-114
- Lerner A, Matthias T (2017) Gluten free diet- tough alley in torrid time. Int J of Celiac Dis 5: 50-55.
- Park YW, Nam MS (2015) Bioactive Peptides in Milk and Dairy Products: A Review. Korean J Food Sci Anim Resour 35: 831-840.
- Haimi M, Lerner A (2014) Nutritional deficiencies in the pediatric age group in a multicultural developed country, Israel. World J Clin Cases 2: 120-125
- Lerner A, Blank M (2014) Hypercoagulability in celiac disease-an update. Autoimmun Rev 13: 1138-1141
- Lerner A, Arleevskaya M, Schmiedl A, Matthias T (2017) Microbes and Viruses Are Bugging the Gut in Celiac Disease. Are They Friends or Foes?. Front Microbiol 8:1392.
- Lerner A, Aminov R, Matthias T (2017) Transglutaminases in Dysbiosis As Potential Environmental Drivers of Autoimmunity. Front Microbiol 8:66.
- Lerner A, Aminov R, Matthias T (2016) Dysbiosis May Trigger Autoimmune Diseases via Inappropriate Post-Translational Modification of Host Proteins. Front Microbiol 7: 84
- Lahat N, Shapiro S, Karban A, Gerstein R, Kinarty A, et al. (1999) Cytokine profile in celiac disease. Scand J Immunol 49: 441-446.
- Lerner A (2010) New Therapeutic Strategies for Celiac Disease. Autoimmun Rev 9: 144-147.
- Hartman C, Hino B, Lerner A, Eshach-Adiv O, Berkovitz D, et al. (2004) Bone quantitative ultrasound and bone mineral density in children with celiac disease. J Pediatr Gastrointerol Nutr 39: 504-510.
- Reifen R, Buskila D, Maislos M, Press J, Lerner A (1997) Serum prolactin in coeliac disease: a marker for disease activity. Arch Dis Child 77: 155-157.
- Shaoul R, Lerner A (2007) Associated autoantibodies in celiac disease. Autoimmun Rev 6: 559-565
- Lucendo AJ, García-Manzanares A (2013) Bone mineral density in adult coeliac disease: an updated review. Rev Esp Enferm Dig 105: 154-162.
- Kamycheva E, Goto T, Camargo CA Jr (2017) Celiac disease is associated with reduced bone mineral density and increased FRAX scores in the US National Health and Nutrition Examination Survey. Osteoporos Int 28: 781-790
- Krupa-Kozak U (2014) Pathologic bone alterations in celiac disease: etiology, epidemiology, and treatment. Nutrition 30: 16-24.
- Rizzoli R (2014) Dairy products, yogurts, and bone health. Am J Clin Nutr 99: 1256S-12562S.
- Caroli A, Poli A, Ricotta D, Banfi G, Cocchi D (2011) Invited review: Dairy intake and bone health: a viewpoint from the state of the art. J Dairy Sci 94: 5249-5262.
- Sahni S, Mangano KM, Kiel DP, Tucker KL, Hannan MT (2017) Dairy Intake Is Protective against Bone Loss in Older Vitamin D Supplement Users: The Framingham Study. J Nutr 147: 645-652.
- Silk LN, Greene DA, Baker MK (2015) The Effect of Calcium or Calcium and Vitamin D Supplementation on Bone Mineral Density in Healthy Males: A Systematic Review and Meta-Analysis. Int J Sport Nutr Exerc Metab 25: 510-524.
- Lerner A, Matthias T (2016) Gut-bone cross talks and implications in celiac disease. Internat J Cliac Dis 4: 19-23
- Nagao-Kitamoto H, Kitamoto S, Kuffa P, Kamada N (2016) Pathogenic role of the gut microbiota in gastrointestinal diseases. Intest Res 14: 127-138.
- Lerner A, Neidhofer S, Matthias T (2016) Nutrients, Bugs and Us: The Short-chain Fatty Acids Story in Celiac Disease. Internat J Celiac Dis 4: 92-94.
- Lerner A, Neidhöfer S, Matthias T (2017) The Gut Microbiome Feelings of the Brain: A Perspective for Non-Microbiologists. Microorganisms 5: 66.
- Tannock GW, Lawley B, Munro K, Gowri Pathmanathan S, Zhou SJ, et al. (2013) Comparison of the compositions of the stool microbiotas of infants fed goat milk formula, cow milk-based formula, or breast milk. Appl Environ Microbiol 79: 3040-3048.
- Sánchez-Moya T, López-Nicolás R, Planes D, González-Bermúdez CA, Ros-Berruezo G, et al. (2017) In vitro modulation of gut microbiota by whey protein to preserve intestinal health. Food Funct 8: 3053-3063.
- Simeoni U, Berger B, Junick J, Blaut M, Pecquet S, et al. (2016) Gut microbiota analysis reveals a marked shift to bifidobacteria by a starter infant formula containing a synbiotic of bovine milk-derived oligosaccharides and Bifidobacterium animalis subsp. lactis CNCM I-3446. Environ Microbiol 18: 2185-2195.
- Macori G, Cotter PD (2017) Novel insights into the microbiology of fermented dairy foods. Curr Opin Biotechnol 49: 172-178.
- Adolfsson O, Meydani SN, Russell RM (2004) Yogurt and gut function. Am J Clin Nutr 80: 245-256.
- Laparra JM, Sanz Y (2010) Bifidobacteria inhibit the inflammatory response induced by gliadins in intestinal epithelial cells via modifications of toxic peptide generation during digestion. J Cell Biochem 109: 801-807.
- Francavilla R, De Angelis M, Rizzello CG, Cavallo N, Dal Bello F, et al. (2017) Selected Probiotic Lactobacilli Have the Capacity To Hydrolyze Gluten Peptides during Simulated Gastrointestinal Digestion. Appl Environ Microbiol 83: e00376-e00317.
- Gülden E, Wong FS, Wen L (2015) The gut microbiota and Type 1 Diabetes. Clin Immunol 159: 143-153.
- Saez-Lara MJ, Gomez-Llorente C, Plaza-Diaz J, Gil A (2015) The role of probiotic lactic acid bacteria and bifidobacteria in the prevention and treatment of inflammatory bowel disease and other related diseases: a systematic review of randomized human clinical trials. Biomed Res Int 2015: 505878.
- Kiseleva EP, Mikhailopulo KI, Sviridov OV, Novik GI, Knirel YA, et al. (2011) The role of components of Bifidobacterium and Lactobacillus in pathogenesis and serologic diagnosis of autoimmune thyroid diseases. Benef Microbes 2: 139-154.
- Olivares M, Albrecht S, De Palma G, Ferrer MD, Castillejo G, et al. (2015) Human milk composition differs in healthy mothers and mothers with celiac disease. Eur J Nutr 54: 119-128.
- Lerner A, Matthias T (2016) GUT-the Trojan horse in remote organs’ autoimmunity. J Clin & Cell Immunol 7: 401.
- Nielsen SS (2002) Plasmin system and microbial proteases in milk: characteristics, roles, and relationship. J Agric Food Chem 50: 6628-6634.
- Reimerdes EH (1983) New aspects of naturally occurring proteases in bovine milk. J Dairy Sci 66: 1591-1600.
- Ollilainen V, Heinonen M, Linkola E, Varo P, Koivistoinen P (1989) Carotenoids and retinoids in Finnish foods: dairy products and eggs. J Dairy Sci 72: 2257-2265.
- Li Y, Gao Y, Cui T, Yang T, Liu L, et al. (2017) Retinoic Acid Facilitates Toll-Like Receptor 4 Expression to Improve Intestinal Barrier Function through Retinoic Acid Receptor Beta. Cell Physiol Biochem 42: 1390-1406.
- Fernandez MA, Marette A (2017) Potential Health Benefits of Combining Yogurt and Fruits Based on Their Probiotic and Prebiotic Properties. Adv Nutr 8: 155-164.
- de los Reyes-Gavilán CG, Fernández M, Hudson JA, Korpela R (2015) Role of microorganisms present in dairy fermented products in health and disease. Biomed Res Int 2015: 204173.
- Bohin MC, Vincken JP, van der Hijden HT, Gruppen H (2012) Efficacy of food proteins as carriers for flavonoids. J Agric Food Chem 60: 4136-4143.
- Panche AN, Diwan AD, Chandra SR (2016) Flavonoids: an overview. J Nutr Sci 5: e47.
- Aryana KJ, Olson DW (2017) A 100-Year Review: Yogurt and other cultured dairy products. J Dairy Sci 100: 9987-10013.
- Lerner A, Neidhöfer S, Matthias T (2016) The gut-gut axis: Cohabitation of celiac, Crohn’s disease and IgA deficiency. Internat J Celiac Dis 4: 68-70.
- Cakebread JA, Humphrey R, Hodgkinson AJ (2015) Immunoglobulin A in Bovine Milk: A Potential Functional Food? J Agric Food Chem 63: 7311-7316.
- Juarez P, Virdi V, Depicker A, Orzaez D (2016) Biomanufacturing of protective antibodies and other therapeutics in edible plant tissues for oral applications. Plant Biotechnol J 14: 1791-1799.
- Vandenplas Y (2015) Lactose intolerance. Asia Pac J Clin Nutr 24: 9-13.
- Hyytinen M, Savilahti E, Virtanen SM, Härkönen T, Ilonen J, et al. (2017) Avoidance of Cow's Milk-Based Formula for At-Risk Infants Does Not Reduce Development of Celiac Disease: A Randomized Controlled Trial. Gastroenterology 153: 961-970.
- Dekking L, Koning F, Hosek D, Ondrak TD, Taylor SL, et al. (2009) Intolerance of celiac disease patients to bovine milk is not due to the presence of T-cell stimulatory epitopes of gluten. Nutrition 25: 122-123.
- Lerner A, Matthias T (2015) Changes in intestinal tight junction permeability associated with industrial food additives explain the rising incidence of autoimmune disease. Autoimmun Rev 14: 479-489
- Lerner A, Matthias T (2015) Possible association between celiac disease and bacterial transglutaminase in food processing: a hypothesis. Nutr Rev 73: 544-552.
- Matthias T, Jeremias P, Neidhöfer S, Lerner A (2016) The industrial food additive microbial transglutaminase, mimics the tissue transglutaminase and is immunogenic in celiac disease patients. Autoimmun Rev 15: 1111-1119.
- Lerner A, Matthias T (2016) Multiple food additives enhance human chronic diseases. SOJ Microbiol Infect Dis 4: 1-2.
- Aaron L (2011) The last two millennias echo-catastrophes are the driving forces for the potential genetic advantage mechanisms in celiac disease. Med Hypotheses 77: 773-776.
- Lerner A, Matthias T, Aminov R (2017) Potential Effects of Horizontal Gene Exchange in the Human Gut. Front Immunol 8: 1630.
- Lerner A, Shoenfeld Y, Matthias T (2017) Adverse effects of gluten ingestion and advantages of gluten withdrawal in nonceliac autoimmune disease. Nutr Rev 75: 1046-1058.
- Kim KS, Hong SW, Han D, Yi J, Jung J, et al. (2016) Dietary antigens limit mucosal immunity by inducing regulatory T cells in the small intestine. Science 351: 858-863.
- McEvoy JD (2016) Emerging food safety issues: An EU perspective. Drug Test Anal 8: 511-520.
- Milk Guidance Documents & Regulatory Information – FDA.
Citation: Aaron L, Torsten M (2018) The Salutogenic Effects of Cow’s Milk and Dairy Products in Celiac Disease. J Clin Cell Immunol 9: 549. Doi: 10.4172/2155-9899.1000549
Copyright: © 2018 Aaron L, et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Select your language of interest to view the total content in your interested language
Share This Article
August 6-7, 2018 Madrid, Spain
September 17-18, 2018 San Diego, USA
December 05-06, 2018 Chicago, USA
- Total views: 355
- [From(publication date): 0-2018 - May 23, 2018]
- Breakdown by view type
- HTML page views: 319
- PDF downloads: 36